Target intelligence / Profile preview

Gag peptide-HLA-A*02 Complex

Molecular classification: Peptide-MHC complex, MHC class I molecule

Overview

The Gag peptide-HLA-A*02 complex refers to a molecular structure in which a peptide derived from the HIV-1 Gag protein is bound and presented by the human leukocyte antigen HLA-A*02, a class I major histocompatibility complex (MHC) molecule. This complex plays a critical role in immune recognition, particularly in the context of cytotoxic T lymphocyte (CTL) responses against HIV-infected cells.

Biological functions

Antigen presentationImmune surveillanceT cell activation

Disease associations

InfectionHIV infection

Beyond the preview

Go deeper on Gag peptide-HLA-A*02 Complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gag peptide-HLA-A*02 Complex.

Explore the full profile